Healthcare | May 17, 2024
Glenmark launches next phase of ‘India First Heart First’ campaign
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
35,000 doctors from across India pledged their support for the initiative to raise awareness about cardiovascular diseases
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
ORACEA is a trademark of Galderma Holdings, S.A.
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
Around 7% of the Indian population suffers from IBS
Ajovy confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month
Subscribe To Our Newsletter & Stay Updated
